CELOX-R Capsule

ក្រុមហ៊ុនផលិតឱសថ:

 

RENATA LIMITED, Bangladesh

  • សារធាតុសកម្ម
  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់
  • ហាមប្រើ
  • ផលរំខាន
  • អន្តរប្រតិកម្ម
  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន
  • ការប្រុងប្រយ័ត្នជាពិសេស
  • សកម្មភាពឱសថ
  • បរិយាយប័ណ្ណឱសថ 
  • សារធាតុសកម្ម

    1. CELOX-R 100 capsule:

    Celecoxib 100mg

    2. CELOX-R 200 capsule:

    Celecoxib 200mg

  • ប្រសិទ្ធិភាពព្យាបាល និង កម្រិតប្រើប្រាស់

    1. For the relief of pain and inflammation of osteoarthritis.

    2. For the relief of pain and inflammation of rheumatoid arthritis

    3. To reduce the number of adenomatous colorectal polyps in familial adenomatous polyposis (FAP); as an adjunct to usual care (e.g. endoscopic surveillance, surgery).

    Dosage and administration

    Osteoarthritis: 200mg/day as a single dose or 100mg twice daily.

    Rheumatoid arthritis: 100-200mg twice daily.

    Familial adenomatous polyposis: To reduce the umber of adenomatous colorectal polyps in patients with FAP, the recommended oral dose is 400mg (2200mg capsules) twice daily to be taken with food.

  • ហាមប្រើ

    In patients with known hypersensitivity to celecoxib.

    To patients who have demonstrated allergic-type reactions to sulfonamides.

    To patients who have demonstrated asthma, urticaria or allergic-type reaction after taking aspirin or other NSAIDs.

  • ផលរំខាន

    Gastrointestinal side effects include abdominal discomfort, diarrhea, dyspepsia, flatulence and nausea.

    Central nervous system side effects include dizziness, headache and insomnia.

    Other side effects include upper respiratory tract infections, skin rash, back pain and peripheral oedema.

  • អន្តរប្រតិកម្ម

    See the package insert about the details below:

    - fluconazole

    - lithium

    - furosemide

    - ACE inhibitors

    - aspirin

    - warfarin

  • ស្ត្រីមានផ្ទៃពោះ និង ស្ត្រីបំបៅដោះកូន

    See the package insert about the details below:

    Pregnancy

    Celecoxib should be used during pregnancy only if the potential benefit justifies the potential risk of the fetus.

    In late pregnancy (third trimester), celecoxib should be avoided because it may cause premature closure of the ductus arteriosus.

    Lactation

    It is not known whether celecoxib is excreted in human milk.

    A decision should be made whether to discontinue the drug, taking into account the importance of the drug to the mother.

  • ការប្រុងប្រយ័ត្នជាពិសេស

    PRECAUTION IN DRUG ADMINISTRATION

    Celox-R, at doses up to 200mg bid, can be administered without regard to timing of meal. Higher doses (400mg bid) should be administered with food.

    Co-administration of Celox-R with an aluminum and magnesium containing antacid should be avoided because they may reduce absorption of celecoxib.

    PRECAUTION IN PATIENTS WITH CV DISEASES

    COX-2 selective inhibitors to be avoided in patients having ischaemic disease or cardiovascular disease.

    PRECAUTION IN PATIENTS WITH CORTICOSTEROID THERAPY

    Celox-R cannot be expected to substitute for corticosteroids or to treat corticosteroid insufficiency. Patients on prolonged corticosteroid therapy should have their therapy tapered slowly if a decision is made to discontinue corticosteroids.

    USE IN SPECIAL POPULATION (see the package insert about the details.)

    Paediatric and Children: Aspirin or other NSAIDs cannot be given in patients with any type of viral infections, especially in children.

  • សកម្មភាពឱសថ

    Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, nonsteroidal anti-inflammatory drug (NSAID). It exhibits anti-inflammatory, analgesic and antipyretic activities. The mechanism of action is believed to be due to the inhibition of COX-2 enzyme. At therapeutic concentration, celecoxib does not inhibit COX-1 isoenzyme.

*ព័ត៌មានឱសថត្រូវបានរៀបរៀងដោយ អ៊ីម៉ាតុគឹ មេឌីក (ខេមបូឌា) ដោយផ្អែកលើប្រភពព័ត៌មានខាងក្រោម។ សម្រាប់ព័ត៌មានលម្អិត សូមស្វែងរកនៅក្នុងក្រដាសព័ត៌មាននៃឱសថនីមួយៗ ឬ សាកសួរទៅកាន់ក្រុមហ៊ុនឱសថឬតំណាងចែកចាយនៃឱសថនីមួយៗ។

ប្រភពព័ត៌មាន៖

- ក្រដាសព័ត៌មាននៃឱសថសម្រាប់អ្នកជំនាញវេជ្ជសាស្ត្រដែលប្រើប្រាស់នៅប្រទេសជប៉ុន (Pharmaceutical and Medical Devices Agency, Pmda): https://www.pmda.go.jp

- ព័ត៌មានសង្ខេបនៃឱសថសម្រាប់អ្នកជំងឺដែលប្រើប្រាស់នៅប្រទេសជប៉ុន: http://www.rad-ar.or.jp